ArticleLife (Basel, Switzerland)2023
Enhancing Sumoylation Site Prediction: A Deep Neural Network with Discriminative Features.
Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- SUMOylation of EphB4 enhances its stability in prostate cancer.British journal of cancer · 2026Article
- Deep learning framework with interpretable feature selection for accurate SUMOylation site prediction.Scientific reports · 2026Article
- Deep capsule neural network for identifying anticancer peptides using sequence to image transformation-based local embedded features.BMC biology · 2026Article
- Chronic liver disease classification using deep learning with SHAP-optimized hybrid features.iScience · 2025Article
- A robust deep learning framework for RNA 5-methyluridine modification prediction using integrated features.BMC biology · 2025Article
- DP-ID: Interleaving and Denoising to Improve the Quality of DNA Storage Image.Interdisciplinary sciences, computational life sciences · 2025Article
- Deep-ProBind: binding protein prediction with transformer-based deep learning model.BMC bioinformatics · 2025Article
- XGBMUT: Predicting the Functional Impact of Missense Mutations Using an Extreme Gradient Boost Classifier.ACS omega · 2025Article
- XGBoost-enhanced ensemble model using discriminative hybrid features for the prediction of sumoylation sites.BioData mining · 2025Article
- Deep-m5U: a deep learning-based approach for RNA 5-methyluridine modification prediction using optimized feature integration.BMC bioinformatics · 2024Article
- A robust deep learning approach for identification of RNA 5-methyluridine sites.Scientific reports · 2024Article
- A hybrid residue based sequential encoding mechanism with XGBoost improved ensemble model for identifying 5-hydroxymethylcytosine modifications.Scientific reports · 2024Article
- PSSM-Sumo: deep learning based intelligent model for prediction of sumoylation sites using discriminative features.BMC bioinformatics · 2024Article
- Sequence based model using deep neural network and hybrid features for identification of 5-hydroxymethylcytosine modification.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sumoylation is a post-translation modification (PTM) mechanism that involves many critical biological processes, such as gene expression, localizing and stabilizing proteins, and replicating the genome. Moreover, sumoylation sites are associated with different diseases, including Parkinson's and Alzheimer's. Due to its vital role in the biological process, identifying sumoylation sites in proteins is significant for monitoring protein functions and discovering multiple diseases. Therefore, in the literature, several computational models utilizing conventional ML methods have been introduced to classify sumoylation sites. However, these models cannot accurately classify the sumoylation sites due to intrinsic limitations associated with the conventional learning methods. This paper proposes a robust computational model (called Deep-Sumo) for predicting sumoylation sites based on a deep-learning algorithm with efficient feature representation methods. The proposed model employs a half-sphere exposure method to represent protein sequences in a feature vector. Principal Component Analysis is applied to extract discriminative features by eliminating noisy and redundant features. The discriminant features are given to a multilayer Deep Neural Network (DNN) model to predict sumoylation sites accurately. The performance of the proposed model is extensively evaluated using a 10-fold cross-validation test by considering various statistical-based performance measurement metrics. Initially, the proposed DNN is compared with the traditional learning algorithm, and subsequently, the performance of the Deep-Sumo is compared with the existing models. The validation results show that the proposed model reports an average accuracy of 96.47%, with improvement compared with the existing models. It is anticipated that the proposed model can be used as an effective tool for drug discovery and the diagnosis of multiple diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.